Oritavancin for the treatment of acute bacterial skin and skin structure infections: an evidence-based review

The emergence of resistance to glycopeptide antibiotics such as vancomycin and teicoplanin among Gram-positive bacteria has spurred the search for second-generation drugs of this class. Oritavancin, a promising novel, second-generation, semisynthetic lipoglycopeptide, is distinguished by two mechani...

Descripción completa

Detalles Bibliográficos
Autores principales: Kmeid, Joumana, Kanafani, Zeina A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334198/
https://www.ncbi.nlm.nih.gov/pubmed/25709561
http://dx.doi.org/10.2147/CE.S51284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334198/
https://www.ncbi.nlm.nih.gov/pubmed/25709561
http://dx.doi.org/10.2147/CE.S51284

Ejemplares similares